Results 31 to 40 of about 446,414 (163)

Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [PDF]

, 2014
The role of systemic chemotherapy (SC) in conjunction with cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in appendiceal mucinous carcinoma peritonei (MCP) is ...
Blackham, Aaron U., Eng, Cathy, Bergman, Simon, Votanopoulos, Konstantinos, Konstantinos Votanopoulos, Levine, Edward A., Edward A. Levine, Geisinger, Kim R, Kim R Geisinger, Stewart, John H., Simon Bergman, Katrina Swett, Shen, Perry, Joseph Sirintrapun, Swett, Katrina, Cathy Eng, Aaron U. Blackham, Sirintrapun, Joseph, Perry Shen, John H. Stewart   +19 more
core   +1 more source

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review

, 2022
Background: Combined treatment modality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is emerging as an alternative option for colorectal peritoneal metastases, but there is ambiguity regarding patient selection, treatment ...
Norbert Garcia-Henriquez, Monson, John R.T., Johnson, Paul, Paul Johnson, Garcia-Hernandez, Norbert, Romanes, Jonathan Paul, Mary E. Spring, Spring, Mary E., Freitag, Harvey E., Harvey E. Freitag, Parikh, Manasi S., Jonathan Paul Romanes, John R.T. Monson, Manasi S. Parikh   +13 more
core   +1 more source

Optimising postoperative care after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Advances in Perioperative Care
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is an aggressive, but increasingly utilised, treatment for advanced peritoneal malignancy.
Laoise Niamh Geoghegan
doaj   +2 more sources

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy

Frontiers in Oncology, 2021
Background: To identify the maximum tolerated dose (MTD) of hyperthermic intraperitoneal cisplatin at 43°C among gynecological cancer patients.Methods: In this Phase I dose-finding trial, Bayesian optimal interval (BOIN) design was used.
Chui-ying Chan, Hui Li, Miao-fang Wu, Chang-hao Liu, Huai-wu Lu, Zhong-qiu Lin, Jing Li   +6 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy in colorectal cancer

BJS Open
Abstract Background This study evaluated the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastases (pmCRC) in a large international data set of patients.
Rau, Beate, Gül-Klein, Safak
openaire   +5 more sources

Perioperative anaesthetic management in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a retrospective analysis in a single tertiary care cancer centre

Pleura and Peritoneum, 2022
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with increased morbidity and mortality. We retrospectively analysed the perioperative anesthetic management in patients undergoing HIPEC surgery.
Gupta Raghav, Gupta Nishkarsh, Sirohiya Prashant, Pandit Anuja, Ratre Brajesh Kumar, Vig Saurabh, Bhan Swati, Singh Ram, Kumar Balbir, Bhopale Shweta, Mishra Seema, Garg Rakesh, Bharati Sachidanand Jee, Kumar Vinod, Deo Suryanarayana, Bhatnagar Sushma   +15 more
doaj   +1 more source

The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer [PDF]

Indian Journal of Surgical Oncology, 2016
Peritoneal metastasis, either synchronous or metachronous, is commonly seen in gastric cancer. It is associated with a poor prognosis, with a median survival of less than one year. The outcomes are not significantly improved by the use of systemic chemotherapy. We review the relevant literature on the role of HIPEC in gastric cancer.
Ramakrishnan Ayloor, Seshadri, Olivier, Glehen   +1 more
openaire   +2 more sources

Simulating drug penetration during hyperthermic intraperitoneal chemotherapy

Drug Delivery, 2021
Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy (41 ...
Daan R. Löke, Roxan F. C. P. A. Helderman, Nicolaas A. P. Franken, Arlene L. Oei, Pieter J. Tanis, Johannes Crezee, H. Petra Kok   +6 more
doaj   +1 more source

Abdominal Wall Morbidity Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

, 2017
Background: Incisional hernia formation has been reported as high as 20% within 1 year following midline laparotomy. Since hyperthermic intraperitoneal chemotherapy is likely to impair wound healing, we sought to investigate the incidence of incisional ...
F. Struller, P. Horvath, I. Koenigsrainer, A. Koenigsrainer, S. Beckert   +4 more
core   +1 more source

Hyperthermic intraperitoneal chemotherapy: Rationale and technique

World Journal of Gastrointestinal Oncology, 2010
The combination of complete cytoreductive surgery and perioperative intraperitoneal chemotherapy provides the only chance for long-term survival for selected patients diagnosed with a variety of peritoneal neoplasms, either primary or secondary to digestive or gynecologic malignancy.
Santiago, González-Moreno, Luis A, González-Bayón, Gloria, Ortega-Pérez   +2 more
openaire   +2 more sources